Broadly, the therapeutic index (TI) for a medication is regarded as that increment of dose above a fully efficacious dose that can be safely tolerated before dose-related adverse effects ensue, and for insulin the TI is generally framed with respect to induction of insulin-induced hypoglycemia and it is notoriously narrow. The gene discussed is INS; the disease is Hypoglycemia.